3',4'-Anhydrovinblastine

CAS No. 38390-45-3

3',4'-Anhydrovinblastine( —— )

Catalog No. M18500 CAS No. 38390-45-3

3', 4'-Anhydrovinblastine is an antineoplastic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 36 Get Quote
25MG 58 Get Quote
50MG 86 Get Quote
100MG 138 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3',4'-Anhydrovinblastine
  • Note
    Research use only, not for human use.
  • Brief Description
    3', 4'-Anhydrovinblastine is an antineoplastic agent.
  • Description
    3', 4'-Anhydrovinblastine is an antineoplastic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    38390-45-3
  • Formula Weight
    792.96
  • Molecular Formula
    C46H56N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCC1=C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Goodbody A, et al. The coupling of catharanthine and vindoline to form 3',4'-anhydrovinblastine by haemoproteins and haemin.[J]. Planta Medica, 1988, 54(03):210-214.
molnova catalog
related products
  • FA-alkyne

    FA-alkyne (FA alkyne) is a fluorescein that is a competitive probe for natural S-succinylation in FH-/- and FH+/+ cells and can be used to synthesize nanophotosensors.

  • D75-4590

    D75-4590 is a β-1,6-Glucan inhibitor. As glucan is a major component of the cell wall, specifically β-1,6-Glucan, D75-4590 can fight fungal infections by inhibiting its synthetase.

  • SJ995973

    SJ995973 is a highly potent bromodomain and extraterminal (BET) protein degrader and a BET PROTAC with potential anticancer activity.